While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Proton pump inhibitors are among the most commonly prescribed medications worldwide, but concerns about a possible link to stomach cancer have lingered for decades. Proton pump inhibitors (PPIs) are a ...

Study should "offer relief" to patients who need long-term therapy for acid-related disord ...

Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma by designing a study that considered the existing literature ...

PPIs have been prescribed worldwide for decades and are among the most commonly used drugs globally. But their prolonged use has raised persistent questions: Could medications meant to protect the ...

A study, published in Gut, examined the relationship between proton pump inhibitor use and gastric cancer incidence rate among Helicobacter pylori-infected patients. Hong Kong, China-based Queen Mary ...

Study finds no stomach cancer link to long-term acid reflux drugs - Early research on the links was ‘hampered by several ...

CHICAGO — Combined use of aspirin and a high-dose proton pump inhibitor (PPI) protects against the development of esophageal cancer in people who are at elevated risk for the malignancy, according to ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be ...